Pliant Therapeutics Inc. (PLRX)
PLRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.9680
-1.83% on the day
Market cap
$59.9M
Micro cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
$149.3M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PLRX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001746473 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | $149.3M |
| Operating income | -$156.4M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $45.4M |
| Total assets | $225.2M |
| P/E (computed) | 0.4× |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-03-30 |
| Latest annual report | 10-K | 2026-03-11 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-11 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 438 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TENX | Tenax Therapeutics Inc. | $1.60 | -12.57% | $59.9M |
| GOSS | Gossamer Bio Inc. | $9.76 | +5.17% | $59.7M |
| XLO | Xilio Therapeutics Inc. | $9.22 | +1.60% | $60.7M |
| VRCA | Verrica Pharmaceuticals Inc. | $3.58 | -10.72% | $61.5M |
| GANX | Gain Therapeutics Inc. | $1.41 | -10.19% | $61.5M |
| APLM | Apollomics Inc. | $21.32 | 0.00% | $61.7M |
| CNTB | Connect Biopharma Holdings Limited | $0.9188 | +1.45% | $57.9M |
| BOLD | Boundless Bio Inc. | $2.43 | -4.71% | $56.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier